Different factors have been proposed to trigger PMD in mast cells in a clinical setting, including chronic psychosocial stress, interactions with regulatory T cells or stimulations of CCL2 and TLR [44]. The gene discussed is CCL2; the disease is Pelizeaus-Merzbacher spectrum disorder.